CER.AX - Stock quotes

Live Stock Quotes - Symbol Lookup

Ticker :	CER.AX
Last Trade :	0.320
Last Trade At :	2/9/2012 11:23pm
Change :	0.000
Opened At :	0.330
Day Range :	0.340 - 0.305
Volume :	7691756
More Details:	http://finance.yahoo.com/q?s=CER.AX

Data delayed by 15 minutes

Detailed Chart for CER.AX and Technical Analysis

News Headlines for CER.AX

IMPORTANT: Bing News RSS feed has moved!
table bgColorffffbb border1pxtdGo to thenbspa hrefhttpapi.bing.comrss.aspxSourceNewsampMarketen-USampVersion2.0 ampQueryCER.AXnew RSS pageanbspand renew your subscription.tdtable

Glaxo Misses Estimates by a Mile - Analyst Blog
Revenues fell 2 year over year at constant exchange rates to 11.2 billion. Revenues came in below the Zacks Consensus Estimate of 11.5 billion. Fiscal 2011 earnings were 3.62 per ADS as compared with 1.66 in the year-ago period. Full-year ...

AZN Beats Estimates by a Whisker
AstraZenecas quarterly revenues remained flat at year over year at 8.7 billion owing to intense generic competition and government price interventions. However revenues were just above the Zacks Consensus Estimate of 8.6 billion.

Glaxo Misses Estimates By A Mile
Revenues fell 2 year over year at constant exchange rates to 11.2 billion. Revenues came in below the Zacks Consensus Estimate of 11.5 billion. Fiscal 2011 earnings were 3.62 per ADS as compared with 1.66 in the year-ago period.

Life Technologies Beats, Profit Up - Analyst Blog
Revenues increased 4 year over year 3 at constant exchange rates or to 970 million surpassing the Zacks Consensus Estimate of 965 million. The performance was marked by strong growth in the Ion Torrent franchise and Forensics. On a geographical ...

BSX Disappoints, Guidance Weak
Excluding the impact from divested businesses and at constant exchange rates net sales dropped 5. For the full year sales dropped 2 5 at to 7.622 billion nominally missing the Zacks Consensus Estimate of 7.662 billion. The ...

NPC Conference to Address Questions on Ability to Share Health Research Findings
To examine key issues around asymmetries or inequalities in communicating health information coming from the growing body of comparative effectiveness research the National Pharmaceutical Council the National Health Council and WellPoint are ...

Sanofi: 2011 Results Benefit from Genzyme Acquisition
Merial sales were up 4.3 which included growth of 12.4 in Emerging Markets. Business EPS1 of euro 6.65 was down 3.8 at . The proposed dividend of euro 2.65 per share corresponds to a payout ratio of 40. Outlook Production recovery is well ...

China Education Resources Inc. Update
VANCOUVER Jan. 31 2012 CNW - China Education Resources Inc. TSXV CHN OTCQX CHNUF a leading technology provider of online learning training courses and tools for teachers students and education professionals in China ...

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca - Press Releases
Earnings were up 12 at constant exchange rates year over year benefiting from share repurchases lower tax rate and lower net finance expense. AstraZenecas quarterly revenues remained flat at year over year at 8.7 billion owing to ...

Farmland on the rise: 2011 brought big increases in tillable land prices
Houston County utilizes a different system called crop equivalent rating to classify land but sales averaged 3010 for typical 70 percent tillable land at the beginning of 2011. That compared to 1085 for 70 percent land in 2001.

Live Stock Quotes